These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7512087)

  • 1. Clinical relevance of breast cancer biology.
    Oza AM; Tannock IF
    Hematol Oncol Clin North Am; 1994 Feb; 8(1):1-14. PubMed ID: 7512087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers for breast cancer.
    Beenken SW; Bland KI
    Minerva Chir; 2002 Aug; 57(4):437-48. PubMed ID: 12145573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic-predictive factors and therapeutic choices in invasive carcinoma of the breast].
    Puglisi F; Di Loreto C; Beltrami CA
    Ann Ital Chir; 1999; 70(3):335-41. PubMed ID: 10466235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.
    Yu H; Levesque MA; Clark GM; Diamandis EP
    Br J Cancer; 1999 Oct; 81(3):490-5. PubMed ID: 10507775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression of p53 and c-erbB2 proteins in breast cancer in Egypt.
    el-A Helal T; Khalifa A; Kamel AS
    Anticancer Res; 2000; 20(3B):2145-50. PubMed ID: 10928168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer molecular subtypes in patients with locally advanced disease: impact on prognosis, patterns of recurrence, and response to therapy.
    Huber KE; Carey LA; Wazer DE
    Semin Radiat Oncol; 2009 Oct; 19(4):204-10. PubMed ID: 19732684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation between apoptotic index, bcl-2 protein expression and progression and prognosis in breast carcinoma].
    Zhang GJ; Kimijima I; Watanabe T; Kanno M; Sagara H; Furukawa Y; Tsuchiya A; Abe R
    Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():415-21. PubMed ID: 9589045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of recurrence for advanced breast cancer. Traditional and contemporary pathologic and molecular markers.
    Masood S
    Surg Oncol Clin N Am; 1995 Oct; 4(4):601-32. PubMed ID: 8535901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene.
    Liu J; Spence MJ; Wallace PM; Forcier K; Hellström I; Vestal RE
    Cell Growth Differ; 1997 Jun; 8(6):667-76. PubMed ID: 9186000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining the molecular biology of inflammatory breast cancer.
    Charafe-Jauffret E; Tarpin C; Viens P; Bertucci F
    Semin Oncol; 2008 Feb; 35(1):41-50. PubMed ID: 18308145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of the new biology for therapy in breast cancer.
    Sledge GW
    Semin Oncol; 1996 Feb; 23(1 Suppl 2):76-81. PubMed ID: 8614850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphatic metastasis of breast cancer cells is associated with differential gene expression profiles that predict cancer stem cell-like properties and the ability to survive, establish and grow in a foreign environment.
    Pandit TS; Kennette W; Mackenzie L; Zhang G; Al-Katib W; Andrews J; Vantyghem SA; Ormond DG; Allan AL; Rodenhiser DI; Chambers AF; Tuck AB
    Int J Oncol; 2009 Aug; 35(2):297-308. PubMed ID: 19578743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Amplification of c-myc and c-erbbeta-2(HER-2/neu) in breast cancer without axillary lymph node metastasis: correlation with other prognostic parameters].
    Lizard-Nacol S; Arnould L; Riedinger JM; Arnal M; Collin F; Guerrin J
    Bull Cancer; 1994 Sep; 81(9):780-4. PubMed ID: 7703567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer metastasis-associated genes: prognostic significance and therapeutic implications.
    Moustafa AS; Nicolson GL
    Oncol Res; 1997; 9(10):505-25. PubMed ID: 9507529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis.
    Pharoah PD; Day NE; Caldas C
    Br J Cancer; 1999 Aug; 80(12):1968-73. PubMed ID: 10471047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Histopathological and molecular biological prognostic indicators of breast cancer].
    Tsuda H
    Gan To Kagaku Ryoho; 1998 Nov; 25(13):2043-8. PubMed ID: 9838905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of p53 gene mutation by polymerase chain reaction-single strand conformation polymorphism provides independent prognostic information in node-negative breast cancer.
    Iacopetta B; Grieu F; Powell B; Soong R; McCaul K; Seshadri R
    Clin Cancer Res; 1998 Jul; 4(7):1597-602. PubMed ID: 9676832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathologic aspects of inflammatory breast cancer: part 2. Biologic insights into its aggressive phenotype.
    Gong Y
    Semin Oncol; 2008 Feb; 35(1):33-40. PubMed ID: 18308144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of mutations to different structural and functional regions of the p53 gene in breast cancer.
    Powell B; Soong R; Iacopetta B; Seshadri R; Smith DR
    Clin Cancer Res; 2000 Feb; 6(2):443-51. PubMed ID: 10690522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic factors for breast cancer].
    Noguchi S; Motomura K; Inaji H; Koyama H
    Gan To Kagaku Ryoho; 1995 Aug; 22(9):1279-84. PubMed ID: 7661581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.